Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ERBB2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 237 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Carraway, KL; Price-Schiavi, SA; Komatsu, M; Jepson, S; Perez, A; Carraway, CAC
      Muc4/sialomucin complex in the mammary gland and breast cancer

      JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
    2. Liu, AY; Chan, WY; Ng, EKW; Zhang, XY; Li, BCY; Chow, JHS; Chung, SC
      Gastric choriocarcinorna shows characteristics of adenocarcinoma and gestational choriocarcinorna: A comparative genomic hybridization and fluorescence in situ hybridization study

      DIAGNOSTIC MOLECULAR PATHOLOGY
    3. Tsongalis, GJ; Ricci, A
      HER2: The Neu prognostic marker for breast cancer

      CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
    4. Ginath, S; Menczer, J; Friedmann, Y; Aingorn, H; Aviv, A; Tajima, K; Dantes, A; Glezerman, M; Vlodavsky, I; Amsterdam, A
      Expression of heparanase, Mdm2, and erbB2 in ovarian cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    5. Ngan, HYS; Cheung, ANY; Liu, SS; Cheng, DKL; Ng, TY; Wong, LC
      Abnormal expression of epidermal growth factor receptor and c-erbB2 in squamous cell carcinoma of the cervix: Correlation with human papillomavirus and prognosis

      TUMOR BIOLOGY
    6. Raj, EH; Skinner, A; Mahji, U; Nirmala, KN; Ravichandran, K; Shanta, V; Hurst, HC; Gullick, WJ; Rajkumar, T
      Neuregulin 1-alpha expression in locally advanced breast cancer

      BREAST
    7. Kristiansen, G; Petersen, YYS; Kaufmann, O; Schluns, K; Dietel, M; Petersen, I
      Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    8. Brodie, SG; Xu, XL; Qiao, WH; Li, WM; Cao, L; Deng, CX
      Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice

      ONCOGENE
    9. Hermanto, U; Zong, CS; Wang, LH
      ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth

      ONCOGENE
    10. Komatsu, M; Jepson, S; Arango, ME; Carraway, CAC; Carraway, KL
      Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor

      ONCOGENE
    11. Brandt, R; Wong, AML; Hynes, NE
      Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells providea novel orthotopic tumor model for testing anti-cancer agents

      ONCOGENE
    12. Aigner, A; Juhl, H; Malerczyk, C; Tkybusch, A; Benz, CC; Czubayko, F
      Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation

      ONCOGENE
    13. Brodie, SG; Xu, XL; Li, CL; Kuo, A; Leder, P; Deng, CX
      Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis

      ONCOGENE
    14. Li, XG; Stuckert, P; Bosch, I; Marks, JD; Marasco, WA
      Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells

      CANCER GENE THERAPY
    15. Lane, HA; Motoyama, AB; Beuvink, I; Hynes, NE
      Modulation of p27/Cdk2 complex formation through 4D5-mediated inhibition of HER2 receptor signaling

      ANNALS OF ONCOLOGY
    16. Lobsiger, CS; Smith, PM; Buchstaller, J; Schweitzer, B; Franklin, RJM; Suter, U; Taylor, V
      SpL201: A conditionally immortalized Schwann cell precursor line that generates myelin

      GLIA
    17. Thomson, TA; Hayes, MM; Spinelli, JJ; Hilland, E; Sawrenko, C; Phillips, D; Dupuis, B; Parker, RL
      HER-2/neu in breast cancer: Interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization

      MODERN PATHOLOGY
    18. Britsch, S; Goerich, DE; Riethmacher, D; Peirano, RI; Rossner, M; Nave, KA; Birchmeier, C; Wegner, M
      The transcription factor Sox10 is a key regulator of peripheral glial development

      GENES & DEVELOPMENT
    19. Harris, LN; Liotcheva, V; Broadwater, G; Ramirez, MJ; Maimonis, P; Anderson, S; Everett, T; Harpole, D; Moore, MB; Berry, DA; Rizzeri, D; Vredenburgh, JJ; Bentley, RC
      Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy

      JOURNAL OF CLINICAL ONCOLOGY
    20. Knoop, AS; Bentzen, SM; Nielsen, MM; Rasmussen, BB; Rose, C
      Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting the efficacy of tamoxifen in high-risk postmenopausal breast cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    21. Cottone, E; Orso, F; Biglia, N; Sismondi, P; De Bortoli, M
      Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    22. Fukushi, Y; Sato, S; Yokoyama, Y; Kudo, K; Maruyama, H; Saito, Y
      Detection of numerical aberration in chromosome 17 and c-erbB2 gene amplification in epithelial ovarian cancer using recently established dual color FISH

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    23. Bieche, I; Onody, P; Lerebours, F; Tozlu, S; Hacene, K; Andrieu, C; Vidaud, M; Tubiana-Hulin, M; Spyratos, F; Lidereau, R
      ERBB2 status and benefit from adjuvant tamoxifen in ER alpha-positive postmenopausal breast carcinoma

      CANCER LETTERS
    24. Ouyang, XM; Gulliford, T; Zhang, HY; Smith, G; Huang, GC; Epstein, RJ
      Association of ErbB2 Ser(1113) phosphorylation with epidermal growth factor receptor co-expression and poor prognosis in human breast cancer

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    25. Liu, ZG; Carvajal, M; Carraway, CAC; Carraway, K; Pflugfelder, SC
      Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia

      CORNEA
    26. Tokita, Y; Keino, H; Matsui, F; Aono, S; Ishiguro, H; Higashiyama, S; Oohira, A
      Regulation of neuregulin expression in the injured rat brain and cultured astrocytes

      JOURNAL OF NEUROSCIENCE
    27. Johannessen, LE; Haugen, KE; Ostvold, AC; Stang, E; Madshus, IH
      Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2and the affinity of EGF binding are regulated by different mechanisms

      BIOCHEMICAL JOURNAL
    28. Eckersley, L; Ansselin, AD; Tomlinson, DR
      Effects of experimental diabetes on axonal and Schwann cell changes in sciatic nerve isografts

      MOLECULAR BRAIN RESEARCH
    29. Park, JW; Kirpotin, DB; Hong, K; Shalaby, R; Shao, Y; Nielsen, UB; Marks, JD; Papahadjopoulos, D; Benz, CC
      Tumor targeting using anti-her2 immunoliposomes

      JOURNAL OF CONTROLLED RELEASE
    30. Lundholt, BK; Briand, P; Lykkesfeldt, AE
      Growth inhibition and growth stimulation by estradiol of estrogen receptortransfected human breast epithelial cell lines involve different pathways

      BREAST CANCER RESEARCH AND TREATMENT
    31. Cheung, KL; Nicholson, RI; Blamey, RW; Robertson, JFR
      Selection of primary breast cancer patients for adjuvant endocrine therapy- is oestrogen receptor alone adequate?

      BREAST CANCER RESEARCH AND TREATMENT
    32. Ambros, IM; Attarbaschi, A; Rumpler, S; Luegmayr, A; Turkof, E; Gadner, H; Ambros, PF
      Neuroblastoma cells provoke Schwann cell proliferation in vitro

      MEDICAL AND PEDIATRIC ONCOLOGY
    33. Wobus, M; Kuns, R; Wolf, C; Horn, LC; Kohler, U; Sheyn, I; Werness, BA; Sherman, LS
      CD44 mediates constitutive type I receptor signaling in cervical carcinomacells

      GYNECOLOGIC ONCOLOGY
    34. Akatsuka, T; Wada, T; Kokai, Y; Sawada, N; Yamawaki, S; Ishii, S
      Loss of ErbB2 expression in pulmonary metastatic lesions in osteosarcoma

      ONCOLOGY
    35. Glockner, S; Lehmann, U; Wilke, N; Kleeberger, R; Langer, F; Kreipe, H
      Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness

      LABORATORY INVESTIGATION
    36. Bei, R; Pompa, G; Vitolo, D; Moriconi, E; Ciocci, L; Quaranta, M; Frati, L; Kraus, MH; Muraro, R
      Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma

      JOURNAL OF PATHOLOGY
    37. Hoffmann, I; Eugene, E; Nassif, X; Couraud, PO; Bourdoulous, S
      Activation of ErbB2 receptor tyrosine kinase supports invasion of endothelial cells by Neisseria meningitidis

      JOURNAL OF CELL BIOLOGY
    38. Anderson, NG; Ahmad, T; Chan, K; Dobson, R; Bundred, NJ
      ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer celllines with or without erbB2 overexpression

      INTERNATIONAL JOURNAL OF CANCER
    39. Egeblad, M; Mortensen, OH; Jaattela, M
      Truncated ErbB2 receptor enhances ErbB1 signaling and induces reversible, ERK-independent loss of epithelial morphology

      INTERNATIONAL JOURNAL OF CANCER
    40. Maletz, K; Kufer, P; Mack, M; Raum, T; Pantel, K; Riethmuller, G; Gruber, R
      Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity

      INTERNATIONAL JOURNAL OF CANCER
    41. Liu, F; Qi, HL; Zhang, Y; Zhang, XY; Chen, HL
      Transfection of the c-erbB2/neu gene upregulates the expression of sialyl Lewis X, alpha 1,3-fucosyltransferase VII, and metastatic potential in a human hepatocarcinoma cell line

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    42. Gilbertson, R; Wickramasinghe, C; Hernan, R; Balaji, V; Hunt, D; Jones-Wallace, D; Crolla, J; Perry, R; Lunec, J; Pearson, A; Ellison, D
      Clinical and molecular stratification of disease risk in medulloblastoma

      BRITISH JOURNAL OF CANCER
    43. Lehr, HA; Jacobs, TW; Yaziji, H; Schnitt, SJ; Gown, AM
      Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis

      AJCP. American journal of clinical pathology
    44. Park, BW; Zhang, HT; Wu, CJ; Berezov, A; Zhang, X; Dua, R; Wang, Q; Kao, G; O'Rourke, DM; Greene, MI; Murali, R
      Rationally designed anti-HER2/neu peptide mimetic disables p185(HER2/neu) tyrosine kinases in vitro and in vivo

      NATURE BIOTECHNOLOGY
    45. Kakar, S; Puangsuvan, N; Stevens, JM; Serenas, R; Mangan, G; Sahai, S; Mihalov, ML
      HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: Comparison of results and correlation with survival

      MOLECULAR DIAGNOSIS
    46. Ross, JS
      The HER-2/neu gene and protein in breast cancer: Methods of detection and clinical significance

      JOURNAL OF CLINICAL LIGAND ASSAY
    47. Shiga, H; Rasmussen, AA; Johnston, PG; Langmacher, M; Baylor, A; Lee, M; Cullen, KJ
      Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    48. Glockner, S; Lehmann, U; Wilke, N; Kleeberger, W; Langer, F; Kreipe, H
      Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR

      PATHOBIOLOGY
    49. Vincent-Salomon, A; Carton, M; Freneaux, P; Palangie, T; Beuzeboc, P; Mouret, E; de Cremoux, P; Coue, O; Zafrani, B; Nicolas, A; Clough, K; Fourquet, A; Pouillart, P; Sastre-Garau, X
      ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy

      EUROPEAN JOURNAL OF CANCER
    50. Mendelsohn, J; Baselga, J
      The EGF receptor family as targets for cancer therapy

      ONCOGENE
    51. Scott, GK; Chang, CH; Erny, KM; Xu, F; Fredericks, WJ; Rauscher, FJ; Thor, AD; Benz, CC
      Ets regulation of the erbB2 promoter

      ONCOGENE
    52. Lim, SJ; Lopez-Berestein, G; Hung, MC; Lupu, R; Tari, AM
      Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells

      ONCOGENE
    53. Yu, DH; Hung, MC
      Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

      ONCOGENE
    54. Newman, SP; Bates, NP; Vernimmen, D; Parker, MG; Hurst, HC
      Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breastcancer

      ONCOGENE
    55. Zhu, XY; Price-Schiavi, SA; Carraway, KL
      Extracellular regulated kinase (ERK)-dependent regulation of sialomucin complex/rat Muc4 in mammary epithelial cells

      ONCOGENE
    56. Kiguchi, K; Bol, D; Carbajal, S; Beltran, L; Moats, S; Chan, K; Jorcano, J; DiGiovanni, J
      Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development

      ONCOGENE
    57. Perissi, V; Menini, N; Cottone, E; Capello, D; Sacco, M; Montaldo, F; De Bortoli, M
      AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen

      ONCOGENE
    58. Stal, O; Borg, A; Ferno, M; Kallstrom, AC; Malmstrom, P; Nordenskjold, B
      ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer

      ANNALS OF ONCOLOGY
    59. Couturier, J; Vincent-Salomon, A; Nicolas, A; Beuzeboc, P; Mouret, E; Zafrani, B; Sastre-Garau, X
      Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

      MODERN PATHOLOGY
    60. Pauletti, G; Dandekar, S; Rong, HM; Ramos, L; Pong, HJ; Seshadri, R; Slamon, DJ
      Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry

      JOURNAL OF CLINICAL ONCOLOGY
    61. Cheung, KL; Pinder, SE; Paish, C; Sadozye, AH; Chan, SY; Evans, AJ; Blamey, RW; Robertson, JFR
      The role of blood tumor marker measurement (using a biochemical index score and c-erbB2) in directing chemotherapy in metastatic breast cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    62. Jeziorski, A; Blonski, JZ; Niewiadomska, H
      The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    63. Kornblum, HI; Yanni, DS; Easterday, MC; Seroogy, KB
      Expression of the EGF receptor family members ErbB2, ErbB3, and ErbB4 in germinal zones of the developing brain and in neurosphere cultures containing CNS stem cells

      DEVELOPMENTAL NEUROSCIENCE
    64. Nguyen, HT; Adam, RM; Bride, SH; Park, JM; Peters, CA; Freeman, MR
      Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    65. Ozaki, M; Tohyama, K; Kishida, H; Buonanno, A; Yano, R; Hashikawa, T
      Roles of neuregulin in synaptogenesis between mossy fibers and cerebellar granule cells

      JOURNAL OF NEUROSCIENCE RESEARCH
    66. Shiku, H; Wang, LJ; Ikuta, Y; Okugawa, T; Schmitt, M; Gu, XG; Akiyoshi, K; Sunamoto, J; Nakamura, H
      Development of a cancer vaccine: peptides, proteins, and DNA

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    67. Vincent, PW; Bridges, AJ; Dykes, DJ; Fry, DW; Leopold, WR; Patmore, SJ; Roberts, BJ; Rose, S; Sherwood, V; Zhou, HR; Elliott, WL
      Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    68. Hurwitz, E; Klapper, LN; Wilchek, M; Yarden, Y; Sela, M
      Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    69. Angus, WGR; Larsen, MC; Jefcoate, CR
      TCDD elevates erbB2 expression and signaling in T47D cells by reversing serum potentiation of estrogen receptor activity, independent of estrogen levels and enhanced ER down-regulation

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    70. McLaughlin, SK
      Erb and c-kit receptors have distinctive patterns of expression in adult and developing taste papillae and taste buds

      JOURNAL OF NEUROSCIENCE
    71. Fry, DW
      Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer

      ANTI-CANCER DRUG DESIGN
    72. Helal, TE; Khalifa, A; Kamel, AS
      Immunohistochemical expression of p53 and c-erbB2 proteins in breast cancer in Egypt

      ANTICANCER RESEARCH
    73. LeVea, CM; McGary, CT; Symons, JR; Mooney, RA
      PTP LAR expression compared to prognostic indices in metastatic and non-metastatic breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    74. Bermont, L; Algros, MP; Baron, MH; Adessi, GL
      Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma

      BREAST CANCER RESEARCH AND TREATMENT
    75. Gerlai, R; Pisacane, P; Erickson, S
      Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks

      BEHAVIOURAL BRAIN RESEARCH
    76. Persons, DL; Bui, MM; Lowery, MC; Mark, HFL; Yung, JF; Birkmeier, JM; Wong, EY; Yang, SJ; Masood, S
      Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: A multicenter portability study

      ANNALS OF CLINICAL AND LABORATORY SCIENCE
    77. Tani, Y
      Molecular analysis and therapeutic application; molecular targeting for breast cancer treatment

      ACTA HISTOCHEMICA ET CYTOCHEMICA
    78. Niewiadomska, H; Mirowski, M; Stempien, M; Blonski, JZ; Czyz, W; Switalska, J; Matyga, E; Hanausek, M; Wierzbicki, R
      Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients

      NEOPLASMA
    79. Nebigil, CG; Choi, DS; Dierich, A; Hickel, P; Le Meur, M; Messaddeq, N; Launay, JM; Maroteaux, L
      Serotonin 2B receptor is required for heart development

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    80. Poul, MA; Becerril, B; Nielsen, UB; Morisson, P; Marks, JD
      Selection of tumor-specific internalizing human antibodies from phage libraries

      JOURNAL OF MOLECULAR BIOLOGY
    81. Darcy, KM; Zangani, D; Wohlhueter, AL; Huang, RY; Vaughan, MM; Russell, JA; Ip, MM
      Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells

      JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    82. Sherman, LS; Rizvi, TA; Karyala, S; Ratner, N
      CD44 enhances neuregulin signaling by Schwann cells

      JOURNAL OF CELL BIOLOGY
    83. Feldman, AM; Lorell, BH; Reis, SE
      Trastuzumab in the treatment of metastatic breast cancer - Anticancer therapy versus cardiotoxicity

      CIRCULATION
    84. Ignatoski, KMW; Maehama, T; Markwart, SM; Dixon, JE; Livant, DL; Ethier, SP
      ERBB-2 overexpression confers PI 3 ' kinase-dependent invasion capacity onhuman mammary epithelial cells

      BRITISH JOURNAL OF CANCER
    85. Miller, MW; Pitts, AF
      Neurotrophin receptors in the somatosensory cortex of the mature rat: co-localization of p75, trk, isoforms and c-neu

      BRAIN RESEARCH
    86. Chen, XM; Yeung, TK; Wang, ZX
      Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    87. Dittadi, R; Gion, M
      More about: Prognostic importance of low c-erbB2 expression in breast tumors

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    88. Spyratos, F; Ferrero-Pous, M; Tubiana-Hulin, M; Hacene, K
      More about: Prognostic importance of low c-erbB2 expression in breast tumors - Response

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    89. Vang, R; Cooley, LD; Harrison, WR; Reese, T; Abrams, J
      Immunohistochemical determination of HER-2/neu expression in invasive breast carcinoma

      AJCP. American journal of clinical pathology
    90. Forus, A; Hoifodt, HK; Overli, GET; Myklebost, O; Fodstad, O
      Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    91. McManus, DT; Patterson, AH; Maxwell, P; Humphreys, MW; Anderson, NH
      Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspirates

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    92. Li, J; Gyorffy, SF; Ring, DB; Kwok, CS; Austin, RC
      Preparation and characterization of a recombinant humanized single-chain Fv antibody/human interleukin-2 fusion protein directed against the HER-2/neu (c-erbB2) proto-oncogene product, p185

      TUMOR TARGETING
    93. Isola, J; Chu, L; DeVries, S; Matsumura, K; Chew, K; Ljung, BM; Waldman, FM
      Genetic alterations in ERBB2-amplified breast carcinomas

      CLINICAL CANCER RESEARCH
    94. Wang, L; Ikeda, H; Ikuta, Y; Schmitt, M; Miyahara, Y; Takahashi, Y; Gu, XG; Nagata, Y; Sasaki, Y; Akiyoshi, K; Sunamoto, J; Nakamura, H; Kuribayashi, K; Shiku, H
      Bone marrow-derived dendritic cells incorporate and process hydrophobized polysaccharide/oncoprotein complex as antigen presenting cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    95. Tari, AM; Hung, MC; Li, KY; Lopez-Berestein, G
      Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells

      ONCOGENE
    96. Liu, XF; Baker, E; Eyre, HJ; Sutherland, GR; Zhou, MD
      gamma-Heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation

      ONCOGENE
    97. Sherman, L; Sleeman, JP; Hennigan, RF; Herrlich, P; Ratner, N
      Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro

      ONCOGENE
    98. Jones, FE; Stern, DF
      Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation

      ONCOGENE
    99. Jacobs, TW; Gown, AM; Yaziji, H; Barnes, MJ; Schnitt, SJ
      Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    100. Jacobs, TW; Gown, AM; Yaziji, H; Barnes, MJ; Schnitt, SJ
      Specificity of HercepTest in determining HER-2/neu status of breast cancers using the united states food and drug administration-approved scoring system

      JOURNAL OF CLINICAL ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 05:10:27